Skip to main content
. 2021 May 11;9(5):565. doi: 10.3390/healthcare9050565

Table 2.

Outcome measures in balance function, activities of daily life, the severity of depressive mood, and cognitive function at baseline (T0) and post-intervention at 4-week follow up (T1).

Outcome
Measure
Control (N = 96) p-Value (95% CI) SAVE (N = 88) p-Value (95% CI)
T0 T1 T0 T1
BBS 26.64 ± 20.79 33.56 ± 20.04 0.000 *(−11.92 to −7.36) 28.05 ± 18.31 39.88 ± 16.70 0.000 *(−14.48 to −9.73)
MBI 49.87 ± 29.43 59.24 ± 26.79 0.000 *(−14.00 to −9.08) 50.46 ± 24.15 66.45 ± 23.03 0.000 *(−22.66 to −15.41)
BDI 14.45 ± 11.60 14.73 ± 12.18 0.157 (−6.32 to 0.86) 12.08 ± 10.30 9.20 ± 9.18 0.087 (−2.21 to 4.31)
MMSE 22.88 ± 7.84 25.26 ± 6.48 0.000 *(−3.39 to −1.85) 23.86 ± 6.15 25.76 ± 5.12 0.000 *(−2.88 to −1.29)
PCS 29.83 ± 10.41 32.29 ± 10.93 0.026 *(−7.70 to −0.51) 30.02 ± 11.06 36.40 ± 10.13 0.000 *(−19.98 to −6.02)
MCS 35.56 ± 11.84 37.32 ± 11.37 0.803 (−22.94 to 19.32) 34.28 ± 9.48 38.53 ± 10.19 0.074 (−9.39 to 0.45)

Each cell represents the mean ± standard deviation. * represents a significant difference within-group comparison between T0 and T1 (p < 0.05). BBS, Berg Balance Scale; BDI, Beck Depression Inventory; MBI, Modified Barthel Index; MMSE, Mini-mental State Examination; MCS, Mental component summary of the Short-Form Survey 36 (SF-36); PCS, Physical component summary of SF-36.